Network-based drug discovery by integrating systems biology and computational technologies

被引:98
作者
Leung, Elaine L. [1 ]
Cao, Zhi-Wei [2 ]
Jiang, Zhi-Hong [1 ]
Zhou, Hua [1 ]
Liu, Liang [3 ]
机构
[1] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
[2] Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
[3] Macau Univ Sci & Technol, Macau, Peoples R China
关键词
network-based drug discovery; systems biology; bioinformatics; computational technologies; network medicine; TRADITIONAL CHINESE MEDICINE; MULTICOMPONENT THERAPEUTICS; MULTITARGET THERAPEUTICS; REGULATORY NETWORKS; HERBAL MEDICINES; CANCER-THERAPY; LUNG-CANCER; IN-VITRO; TARGET; COMBINATION;
D O I
10.1093/bib/bbs043
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
Network-based intervention has been a trend of curing systemic diseases, but it relies on regimen optimization and valid multi-target actions of the drugs. The complex multi-component nature of medicinal herbs may serve as valuable resources for network-based multi-target drug discovery due to its potential treatment effects by synergy. Recently, robustness of multiple systems biology platforms shows powerful to uncover molecular mechanisms and connections between the drugs and their targeting dynamic network. However, optimization methods of drug combination are insufficient, owning to lacking of tighter integration across multiple '-omics' databases. The newly developed algorithm- or network-based computational models can tightly integrate '-omics' databases and optimize combinational regimens of drug development, which encourage using medicinal herbs to develop into new wave of network-based multi-target drugs. However, challenges on further integration across the databases of medicinal herbs with multiple system biology platforms for multi-target drug optimization remain to the uncertain reliability of individual data sets, width and depth and degree of standardization of herbal medicine. Standardization of the methodology and terminology of multiple system biology and herbal database would facilitate the integration. Enhance public accessible databases and the number of research using system biology platform on herbal medicine would be helpful. Further integration across various '-omics' platforms and computational tools would accelerate development of network-based drug discovery and network medicine.
引用
收藏
页码:491 / 505
页数:15
相关论文
共 89 条
[1]
Systematic discovery of multicomponent therapeutics [J].
Borisy, AA ;
Elliott, PJ ;
Hurst, NW ;
Lee, MS ;
Lehár, J ;
Price, ER ;
Serbedzija, G ;
Zimmermann, GR ;
Foley, MA ;
Stockwell, BR ;
Keith, CT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7977-7982
[2]
Borkow G., 2005, Current Drug Targets - Infectious Disorders, V5, P3, DOI 10.2174/1568005053174645
[3]
Towards semantic e-Science for Traditional Chinese Medicine [J].
Chen, Huajun ;
Mao, Yuxin ;
Zheng, Xiaoqing ;
Cui, Meng ;
Feng, Yi ;
Deng, Shuiguang ;
Yin, Aining ;
Zhou, Chunying ;
Tang, Jinming ;
Jiang, Xiaohong ;
Wu, Zhaohui .
BMC BIOINFORMATICS, 2007, 8 (Suppl 3)
[4]
Serum 27-nor-5β-Cholestane-3,7,12,24,25 Pentol Glucuronide Discovered by Metabolomics as Potential Diagnostic Biomarker for Epithelium Ovarian Cancer [J].
Chen, Jing ;
Zhang, Xiaoyan ;
Cao, Rui ;
Lu, Xin ;
Zhao, Sumin ;
Fekete, Agnes ;
Huang, Qiang ;
Schmitt-Kopplin, Philippe ;
Wang, Yisheng ;
Xu, Zhiliang ;
Wan, Xiaoping ;
Wu, Xiaohua ;
Zhao, Naiqing ;
Xu, Congjian ;
Xu, Guowang .
JOURNAL OF PROTEOME RESEARCH, 2011, 10 (05) :2625-2632
[5]
Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes [J].
Chen, Rui ;
Mias, George I. ;
Li-Pook-Than, Jennifer ;
Jiang, Lihua ;
Lam, Hugo Y. K. ;
Chen, Rong ;
Miriami, Elana ;
Karczewski, Konrad J. ;
Hariharan, Manoj ;
Dewey, Frederick E. ;
Cheng, Yong ;
Clark, Michael J. ;
Im, Hogune ;
Habegger, Lukas ;
Balasubramanian, Suganthi ;
O'Huallachain, Maeve ;
Dudley, Joel T. ;
Hillenmeyer, Sara ;
Haraksingh, Rajini ;
Sharon, Donald ;
Euskirchen, Ghia ;
Lacroute, Phil ;
Bettinger, Keith ;
Boyle, Alan P. ;
Kasowski, Maya ;
Grubert, Fabian ;
Seki, Scott ;
Garcia, Marco ;
Whirl-Carrillo, Michelle ;
Gallardo, Mercedes ;
Blasco, Maria A. ;
Greenberg, Peter L. ;
Snyder, Phyllis ;
Klein, Teri E. ;
Altman, Russ B. ;
Butte, Atul J. ;
Ashley, Euan A. ;
Gerstein, Mark ;
Nadeau, Kari C. ;
Tang, Hua ;
Snyder, Michael .
CELL, 2012, 148 (06) :1293-1307
[6]
Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation [J].
Chen, X. ;
Zhou, H. ;
Liu, Y. B. ;
Wang, J. F. ;
Li, H. ;
Ung, C. Y. ;
Han, L. Y. ;
Cao, Z. W. ;
Chen, Y. Z. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (08) :1092-1103
[7]
In cancer drug resistance, germline matters too [J].
Cheng, Emily H. ;
Sawyers, Charles L. .
NATURE MEDICINE, 2012, 18 (04) :494-496
[8]
COMPUTERIZED QUANTITATION OF SYNERGISM AND ANTAGONISM OF TAXOL, TOPOTECAN, AND CISPLATIN AGAINST HUMAN TERATOCARCINOMA CELL-GROWTH - A RATIONAL APPROACH TO CLINICAL PROTOCOL DESIGN [J].
CHOU, TC ;
MOTZER, RJ ;
TONG, YZ ;
BOSL, GJ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (20) :1517-1524
[9]
QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[10]
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method [J].
Chou, Ting-Chao .
CANCER RESEARCH, 2010, 70 (02) :440-446